437 related articles for article (PubMed ID: 16267627)
1. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
van Schaik RH
Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
[TBL] [Abstract][Full Text] [Related]
2. Implications of cytochrome P450 genetic polymorphisms on the toxicity of antitumor agents.
van Schaik RH
Ther Drug Monit; 2004 Apr; 26(2):236-40. PubMed ID: 15228172
[TBL] [Abstract][Full Text] [Related]
3. CYP450 pharmacogenetics for personalizing cancer therapy.
van Schaik RH
Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 in Pharmacogenetics: An Update.
Tornio A; Backman JT
Adv Pharmacol; 2018; 83():3-32. PubMed ID: 29801580
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 pharmacogenetics and cancer.
Rodriguez-Antona C; Ingelman-Sundberg M
Oncogene; 2006 Mar; 25(11):1679-91. PubMed ID: 16550168
[TBL] [Abstract][Full Text] [Related]
6. Cancer pharmacogenomics: achievements in basic research.
Nakajima M; Yokoi T
Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
[TBL] [Abstract][Full Text] [Related]
7. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment.
Mathijssen RH; van Schaik RH
Eur J Cancer; 2006 Jan; 42(2):141-8. PubMed ID: 16325399
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.
Sim SC; Kacevska M; Ingelman-Sundberg M
Pharmacogenomics J; 2013 Feb; 13(1):1-11. PubMed ID: 23089672
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of the major polymorphic metabolizing enzymes.
Daly AK
Fundam Clin Pharmacol; 2003 Feb; 17(1):27-41. PubMed ID: 12588628
[TBL] [Abstract][Full Text] [Related]
11. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Deeken JF; Figg WD; Bates SE; Sparreboom A
Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 in Cancer Susceptibility and Treatment.
Mittal B; Tulsyan S; Kumar S; Mittal RD; Agarwal G
Adv Clin Chem; 2015; 71():77-139. PubMed ID: 26411412
[TBL] [Abstract][Full Text] [Related]
13. Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.
Rochat B
Clin Pharmacokinet; 2005; 44(4):349-66. PubMed ID: 15828850
[TBL] [Abstract][Full Text] [Related]
14. Significant role of CYP450 genetic variants in cyclophosphamide based breast cancer treatment outcomes: a multi-analytical strategy.
Tulsyan S; Agarwal G; Lal P; Mittal B
Clin Chim Acta; 2014 Jul; 434():21-8. PubMed ID: 24768782
[TBL] [Abstract][Full Text] [Related]
15. Cancer therapy and polymorphisms of cytochromes P450.
MacLeod SL; Nowell S; Massengill J; Jazieh A; McClure G; Plaxco J; Kadlubar FF; Lan NP
Clin Chem Lab Med; 2000 Sep; 38(9):883-7. PubMed ID: 11097344
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
Oscarson M
Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
Bosch TM; Meijerman I; Beijnen JH; Schellens JH
Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
[TBL] [Abstract][Full Text] [Related]
18. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
[TBL] [Abstract][Full Text] [Related]
19. African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.
Rajman I; Knapp L; Morgan T; Masimirembwa C
EBioMedicine; 2017 Mar; 17():67-74. PubMed ID: 28237373
[TBL] [Abstract][Full Text] [Related]
20. Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.
Bertholee D; Maring JG; van Kuilenburg AB
Clin Pharmacokinet; 2017 Apr; 56(4):317-337. PubMed ID: 27641154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
